Amanote Research

Amanote Research

    RegisterSign In

182. Characterization and AAV-Mediated Correction of Xeroderma Pigmentosum-Cockayne Syndrome (XP/CS)

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33787-x
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
Date

May 1, 2015

Authors
Skylar A. RizzoAmy L. DonateBennett J. GosikerKatherine E. SantostefanoNaohiro TeradaFowzan S. AlkurayaPeter B. KangChristina A. Pacak
Publisher

Elsevier BV


Related search

Basal Cell Epithelioma in a Xeroderma Pigmentosum (XP) Patient.

Skin Cancer
1993English

Xeroderma Pigmentosum

British Medical Journal
Medicine
2008English

Xeroderma Pigmentosum

Annals of King Edward Medical University
2016English

Xeroderma Pigmentosum

Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan
Medicine
1979English

Cockayne Syndrome (Cs) Masquerading as Seckel Syndrome (Ss)

Pediatric Research
Child HealthPediatricsPerinatology
1987English

Xeroderma Pigmentosum

Aktuelle Dermatologie
Dermatology
2007English

Ocular Manifestations of Xeroderma Pigmentosum

Ophthalmology
Ophthalmology
2013English

Xeroderma Pigmentosum With Ocular Complications

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1963English

Xeroderma Pigmentosum: Exenteration of Palpebral Basocellular Carcinoma

Scholars Journal of Medical Case Reports
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy